Grail
ISIN US3847471014
|WKN A40F8M
Overview
Description
GRAIL, Inc. is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.
Healthcare Healthcare Equipment Diagnostics and Drug Delivery Devices United States
Financials
Key metrics
| Market capitalisation, EUR | 744.00 m |
| EPS, EUR | -59.87 |
| P/B ratio | 0.32 |
| P/E ratio | - |
| Dividend yield | 0.00% |
Income statement (2024)
| Revenue, EUR | 116.11 m |
| Net income, EUR | -1,873.92 m |
| Profit margin | -1,613.92% |
What ETF is Grail in?
There are 12 ETFs which contain Grail. All of these ETFs are listed in the table below. The ETF with the largest weighting of Grail is the L&G Healthcare Breakthrough UCITS ETF USD Acc.
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
